HomeCompareTBGNF vs JEPI

TBGNF vs JEPI: Dividend Comparison 2026

TBGNF yields 1176.47% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBGNF wins by $78814195.17M in total portfolio value
10 years
TBGNF
TBGNF
● Live price
1176.47%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78814195.20M
Annual income
$67,523,701,253,088.38
Full TBGNF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — TBGNF vs JEPI

📍 TBGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBGNFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBGNF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBGNF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBGNF
Annual income on $10K today (after 15% tax)
$100,000.00/yr
After 10yr DRIP, annual income (after tax)
$57,395,146,065,125.13/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, TBGNF beats the other by $57,395,146,063,825.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBGNF + JEPI for your $10,000?

TBGNF: 50%JEPI: 50%
100% JEPI50/50100% TBGNF
Portfolio after 10yr
$39407097.62M
Annual income
$33,761,850,627,308.50/yr
Blended yield
85.67%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBGNF buys
0
JEPI buys
0
No recent congressional trades found for TBGNF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBGNFJEPI
Forward yield1176.47%8.40%
Annual dividend / share$2.00$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$78814195.20M$29.0K
Annual income after 10y$67,523,701,253,088.38$1,528.62
Total dividends collected$77969765.27M$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: TBGNF vs JEPI ($10,000, DRIP)

YearTBGNF PortfolioTBGNF Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$128,347$117,647.06$11,260$840.19+$117.1KTBGNF
2$1,548,514$1,411,182.61$12,641$907.94+$1.54MTBGNF
3$17,569,052$15,912,142.01$14,150$978.20+$17.55MTBGNF
4$187,523,354$168,724,468.35$15,795$1,050.85+$187.51MTBGNF
5$1,883,716,681$1,683,066,692.55$17,584$1,125.74+$1883.70MTBGNF
6$17,816,329,317$15,800,752,468.33$19,526$1,202.74+$17816.31MTBGNF
7$158,731,384,105$139,667,911,735.60$21,628$1,281.69+$158731.36MTBGNF
8$1,332,782,916,056$1,162,940,335,063.89$23,898$1,362.43+$1332782.89MTBGNF
9$10,551,863,503,163$9,125,785,782,982.70$26,347$1,444.79+$10551863.48MTBGNF
10$78,814,195,201,473$67,523,701,253,088.38$28,982$1,528.62+$78814195.17MTBGNF

TBGNF vs JEPI: Complete Analysis 2026

TBGNFStock

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Full TBGNF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this TBGNF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBGNF vs SCHDTBGNF vs OTBGNF vs KOTBGNF vs MAINTBGNF vs JEPQTBGNF vs XYLDTBGNF vs DIVOTBGNF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.